BR0111445A - Composto esteróide, método para a modificaçao seletiva da atividade de receptores de estrogênio, uso do composto esteróide, e, composição farmacêutica - Google Patents
Composto esteróide, método para a modificaçao seletiva da atividade de receptores de estrogênio, uso do composto esteróide, e, composição farmacêuticaInfo
- Publication number
- BR0111445A BR0111445A BR0111445-0A BR0111445A BR0111445A BR 0111445 A BR0111445 A BR 0111445A BR 0111445 A BR0111445 A BR 0111445A BR 0111445 A BR0111445 A BR 0111445A
- Authority
- BR
- Brazil
- Prior art keywords
- steroid compound
- alkyl
- estrogen receptor
- receptor activity
- alkenyl
- Prior art date
Links
- -1 Steroid Compound Chemical class 0.000 title abstract 5
- 102000015694 estrogen receptors Human genes 0.000 title abstract 3
- 108010038795 estrogen receptors Proteins 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000012986 modification Methods 0.000 title abstract 3
- 230000004048 modification Effects 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000003342 alkenyl group Chemical group 0.000 abstract 4
- 125000000304 alkynyl group Chemical group 0.000 abstract 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 2
- 125000001118 alkylidene group Chemical group 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 2
- 229910052731 fluorine Inorganic materials 0.000 abstract 2
- 239000011737 fluorine Substances 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 150000003431 steroids Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00201986 | 2000-06-06 | ||
| PCT/EP2001/004868 WO2002000682A1 (en) | 2000-06-06 | 2001-05-01 | 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0111445A true BR0111445A (pt) | 2003-06-03 |
Family
ID=8171601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0111445-0A BR0111445A (pt) | 2000-06-06 | 2001-05-01 | Composto esteróide, método para a modificaçao seletiva da atividade de receptores de estrogênio, uso do composto esteróide, e, composição farmacêutica |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US7868193B2 (enExample) |
| EP (1) | EP1294739B1 (enExample) |
| JP (1) | JP5095902B2 (enExample) |
| KR (1) | KR100769865B1 (enExample) |
| CN (1) | CN1235908C (enExample) |
| AR (1) | AR028080A1 (enExample) |
| AT (1) | ATE293124T1 (enExample) |
| AU (2) | AU5838601A (enExample) |
| BR (1) | BR0111445A (enExample) |
| CA (1) | CA2410220C (enExample) |
| CZ (1) | CZ20024014A3 (enExample) |
| DE (1) | DE60110069T2 (enExample) |
| DK (1) | DK1294739T3 (enExample) |
| ES (1) | ES2240454T3 (enExample) |
| HU (1) | HUP0301190A3 (enExample) |
| IL (1) | IL152957A0 (enExample) |
| MX (1) | MXPA02012117A (enExample) |
| NO (1) | NO324247B1 (enExample) |
| PE (1) | PE20020214A1 (enExample) |
| PL (1) | PL203732B1 (enExample) |
| PT (1) | PT1294739E (enExample) |
| RU (1) | RU2255090C2 (enExample) |
| SK (1) | SK286852B6 (enExample) |
| TW (1) | TWI225068B (enExample) |
| WO (1) | WO2002000682A1 (enExample) |
| ZA (1) | ZA200209452B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8367648B2 (en) | 2009-06-10 | 2013-02-05 | Msd Oss B.V. | Substituted 16,17-annellated steroid compounds for use in womens healthcare |
| TW201109346A (en) * | 2009-06-10 | 2011-03-16 | Organon Nv | Substituted 16,17-annellated steroid compounds for use in women's healthcare |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3194821A (en) * | 1963-12-30 | 1965-07-13 | Abbott Lab | 17alpha-substituted 17beta-hydroxyestrenes |
| CA2200423C (en) | 1996-03-26 | 2006-12-19 | Sietse Mosselman | Novel estrogen receptor |
| IL123195A (en) * | 1997-02-21 | 2002-11-10 | Akzo Nobel Nv | Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them |
-
2001
- 2001-04-17 TW TW090109186A patent/TWI225068B/zh not_active IP Right Cessation
- 2001-05-01 IL IL15295701A patent/IL152957A0/xx not_active IP Right Cessation
- 2001-05-01 EP EP01931676A patent/EP1294739B1/en not_active Expired - Lifetime
- 2001-05-01 RU RU2002135594/04A patent/RU2255090C2/ru not_active IP Right Cessation
- 2001-05-01 WO PCT/EP2001/004868 patent/WO2002000682A1/en not_active Ceased
- 2001-05-01 PL PL359238A patent/PL203732B1/pl not_active IP Right Cessation
- 2001-05-01 DK DK01931676T patent/DK1294739T3/da active
- 2001-05-01 US US10/297,706 patent/US7868193B2/en not_active Expired - Fee Related
- 2001-05-01 ES ES01931676T patent/ES2240454T3/es not_active Expired - Lifetime
- 2001-05-01 AT AT01931676T patent/ATE293124T1/de active
- 2001-05-01 BR BR0111445-0A patent/BR0111445A/pt not_active IP Right Cessation
- 2001-05-01 JP JP2002505804A patent/JP5095902B2/ja not_active Expired - Fee Related
- 2001-05-01 CZ CZ20024014A patent/CZ20024014A3/cs unknown
- 2001-05-01 AU AU5838601A patent/AU5838601A/xx active Pending
- 2001-05-01 AU AU2001258386A patent/AU2001258386B2/en not_active Ceased
- 2001-05-01 KR KR1020027016657A patent/KR100769865B1/ko not_active Expired - Fee Related
- 2001-05-01 MX MXPA02012117A patent/MXPA02012117A/es active IP Right Grant
- 2001-05-01 PT PT01931676T patent/PT1294739E/pt unknown
- 2001-05-01 HU HU0301190A patent/HUP0301190A3/hu unknown
- 2001-05-01 SK SK1707-2002A patent/SK286852B6/sk not_active IP Right Cessation
- 2001-05-01 CN CNB018107451A patent/CN1235908C/zh not_active Expired - Fee Related
- 2001-05-01 CA CA002410220A patent/CA2410220C/en not_active Expired - Fee Related
- 2001-05-01 DE DE60110069T patent/DE60110069T2/de not_active Expired - Lifetime
- 2001-05-03 PE PE2001000401A patent/PE20020214A1/es not_active Application Discontinuation
- 2001-05-04 AR ARP010102107A patent/AR028080A1/es unknown
-
2002
- 2002-11-20 ZA ZA200209452A patent/ZA200209452B/en unknown
- 2002-12-02 NO NO20025793A patent/NO324247B1/no not_active IP Right Cessation
-
2010
- 2010-06-15 US US12/816,058 patent/US20100249083A1/en not_active Abandoned
-
2011
- 2011-05-20 US US13/112,184 patent/US20110224183A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0307406A (pt) | Indóis substituìdos como agonistas alfa-1 | |
| BR0108600A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, métodos para tratamento de uma doença mediada por quimiocina e para tratamento de uma doença inflamatória | |
| GT199900146A (es) | Derivados de 4,4-biarilpiperidina. | |
| BR0210929A (pt) | Derivados de indol com afinidade para o receptor 5-ht6 | |
| PA8461301A1 (es) | Agonistas de prostaglandinas | |
| BR9812176A (pt) | Antagonista de receptor il-8 | |
| NO20003546L (no) | Anvendelse av progestin og en farmasøytisk sammensetning samt et kit inneholdende disse | |
| BR9713704A (pt) | Ceto-benzamida, uso da mesma, e, preparação de droga | |
| BR0307429A (pt) | Composto, uso do mesmo, composição farmacêutica, e, método para o tratamento de distúrbios ou doenças relacionadas com receptor de histamina h3 | |
| EA200000718A1 (ru) | Композиции целекоксиба | |
| PE20010613A1 (es) | Antagonistas de la hormona concentradora de la melanina | |
| EA199700044A1 (ru) | Эстрогенные агенты | |
| KR870003974A (ko) | 비시클로 치환된 페닐아세토니트릴 유도체 | |
| ES2163407T3 (es) | Derivados piperidinilos tiaciclicos. | |
| BR9810163A (pt) | Compostos ou suas composições | |
| KR910004650A (ko) | C_17-20 리아제 억제제로 유용한 4-치환 17β-(시클로프로필옥시) 안드로스트-5-엔-3β-올 및 그의 관련 화합물 | |
| BR9713302A (pt) | Derivado de eritromicina a, composição farmacêutica, preparação antibacteriana, processo para o tratamento de uma doença bacteriologicamente infecciosa, e, uso do derivado de eritromicina a ou um seu sal farcamaceuticamente aceitável. | |
| AR016054A1 (es) | Mezcla de ácidos grasos primarios , uso de la mezcla y método para obtener la misma | |
| BR9812236A (pt) | Combinação de componentes, uso desta, processos para a preparação da mesma, para o tratamento de distúrbios afetivos, para o tratamento de depressão, e para melhorar o inìcio de ação terapêutica, formulação farmacêutica, e, kit | |
| BRPI0413013A (pt) | composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças | |
| AR015446A1 (es) | Antagonistas de receptores de vitronectina, composicion farmaceutica que los contiene, procedimiento para su preparacion, su uso para la elaboracion de unmedicamento y compuestos intermediarios | |
| BR9808042A (pt) | Composto, composição farmacêutica, e, processo para preparação de compostos. | |
| BR0111445A (pt) | Composto esteróide, método para a modificaçao seletiva da atividade de receptores de estrogênio, uso do composto esteróide, e, composição farmacêutica | |
| AU3422800A (en) | Use of 5-ht3 receptor antagonists | |
| ATE44282T1 (de) | 6-oder-7-methylenandrosta-1,4-dien-3,17-dionderivate und verfahren zu ihrer herstellung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 11A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012. |